Back to Search
Start Over
Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib.
- Source :
- Clinical Case Reports; Apr2021, Vol. 9 Issue 4, p2228-2235, 8p
- Publication Year :
- 2021
-
Abstract
- An 83‐year‐old female had asymptomatic SARS‐CoV‐2 infection while taking ruxolitinib. She remained RT‐PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations support combination therapy of ruxolitinib + interferon for COVID‐19. [ABSTRACT FROM AUTHOR]
- Subjects :
- OLDER women
INTERFERONS
MYELOFIBROSIS
COVID-19
SARS-CoV-2
Subjects
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 9
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- 150026120
- Full Text :
- https://doi.org/10.1002/ccr3.3997